American Bio Medica's oxycodone assay gains US nod:
This article was originally published in Clinica
American Bio Medica Corporation has received US FDA 510(k) clearance for what it claims is the first on-site, point-of-care test for oxycodone, a synthetic opiate found in commonly abused prescription painkillers, including OxyContin. The Rapid One OXY assay is a urine-based test that can provide results within minutes. It is designed to detect oxycodone at a very low level and does not detect other opiates at this level, says the Kinderhook, New York firm.